ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Health Care / PARK / options
CCEL (70) VMD (72) NIVF (20) AGL (36) ⌘ Pro Terminal →

Park Dental Partners Inc. (PARK) Options Positioning, Max Pain & Unusual Sweeps

$20.65 -2.09% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $20.53

Park Dental Partners Inc. (PARK) carries a Roarable Rating of C- (Hold) with 60/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C- • HOLD / WATCH Cap $100.3M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on PARK Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is PARK stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Park Dental Partners Inc. (NASDAQ: PARK) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 60/100 at a spot price of $20.65 (-2.09% 1D, market cap $100.3M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 9/20. Active quantitative signal LIQUIDITY_TAILWIND (BULLISH, conviction undefined/100) notes: undefined.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does PARK compare to CCEL and VMD in the Health Care sector?
▼

Within the Health Care sector (Misc Health and Biotechnology Services), PARK carries a Roarable C- (60/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, CCEL (Cryo-Cell International Inc.) holds a B- grade (70/100 RQD, P/E N/A, ROIC 18.2%, cap $42.0M) and VMD (Viemed Healthcare Inc.) posts a B grade (72/100 RQD, P/E 24.6x, ROIC 13.0%, cap $368.3M). Among the 5-stock peer group, VMD leads on earnings multiple (24.6x) while CCEL leads on capital efficiency (18.2% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for PARK?
▼

Per PARK's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0002069604), Park Dental Partners Inc. generated $74.8M in revenue, $0 in net income, and $0 in free cash flow against $178.2M in total assets and $10.1M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $20.53 (-0.57%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 3.8% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 60/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.4% avg 90D alpha vs SPY • 53.5% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERHOLD / WATCH • C-
025507510060
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk B-
Cash (10)Whales (13)SEC (13)Macro (15)CEO (9)
Each axis scored 0–20
12M PRICE TARGET CONE+0.9% Base Target
$28 Bull$21 Base$16 Bear
📬 FREE PARK RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PARK)Realized 20D OHLCV Swing Band: ±12.4%
Deterministic 5-Pillar Attribution (60/100 Composite)
🔍 WHY PARK SCORES 60/100 (C-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Macro Regime Fit+15/20 pts (25% of score)

FRED Regime × Technicals: 64% of 52W Range • RSI-14 at 56.4 (BULLISH MOMENTUM)

▲ #2 Bullish Driver: Whale & Options Positioning+13/20 pts (22% of score)

20D Institutional Volume Accumulation (±12.4% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)

Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
52
Grade C-$19.59+2.1% Next Q
Q2 (-2Q)
55
Grade C$20.00-3.5% Next Q
Q3 (-1Q)
57
Grade C$19.31+6.9% Next Q
Current
60
Grade C-$20.65+0.4% Hist 90D α
Trajectory: C- (52) → C- (60)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the PARK Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 60/100 (C-) score, PARK faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Disciplined Float (-0.40% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($20.31) or 200D SMA ($19.03) invalidates the momentum regime and cuts Target Base ($20.84) toward Bear Floor ($16.26).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $PARK• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “PARK Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 60%NO 40%Trade / Inspect Odds →
CALL VS. PUT WHALE SHARE
— (No Active Options Snapshot)
Put/Call Ratio: — (No Active Options Snapshot)
MAX-PAIN EXPIRATION MAGNET
— (No Active Options Snapshot)
No active options chain max-pain snapshot on file
HISTORICAL 20D VOLATILITY SWING
±12.4%
Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (PARK)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for PARK.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating PARK & AI Leaders Without Chasing Tops

  • ✓Institutional whale strikes & implied earnings move audit on PARK
  • ✓How disciplined traders manage risk using pre-published trigger & invalidation levels
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
PARK // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +16.73%⚡ TESTING RESISTANCE
2026-11-03O $20.06H $21.09L $20.06C $20.65VOL 158.6K
RES: $21.49SUP: $17.81SMA50: $20.31SMA200: $19.03
$27.50$24.56$21.62$18.69$15.75RES $21.49SUP $17.81$20.652026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PARK Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 PARK Butterfly Map → + Track PARK →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on PARK today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PARK. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for PARK today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PARK)

Health Care Rank #165 of 1016 ⚔️ CCEL vs PARK Full Matrix →

1. Head-to-Head Health Care Peer Comparison (PARK vs. CCEL, VMD, NIVF, AGL)

Industry: Misc Health and Biotechnology Services (10 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Park Dental Partners Inc. (PARK) ranks #165 by composite RQD confidence (60/100, grade C-) and #652 by equity capitalization ($100.3M). Within this direct 5-issuer industry benchmark cohort, VMD leads on earnings valuation at 24.6x trailing P/E, while CCEL leads on capital efficiency and profitability with 18.2% ROIC and — gross margin. VMD currently holds the highest overall quantitative score in the immediate peer group at 72/100 (B) compared with PARK at 60/100 (C-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
PARK ACTIVE
Park Dental Partners Inc.
C- 60/100 — — — -2.09% $100.3M Benchmark Subject
CCEL
Cryo-Cell International Inc.
B- 70/100 — — 18.2% +2.69% $42.0M /ccel-vs-park →
VMD
Viemed Healthcare Inc.
B 72/100 24.6x 57.5% 13.0% -2.38% $368.3M /vmd-vs-park →
NIVF
NewGenIvf Group Limited (Class A)
E 20/100 — — -32.8% -5.57% $9.7M /nivf-vs-park →
AGL
agilon health inc.
D- 36/100 — — -35.0% +2.04% $1.43B /agl-vs-park →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2025–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0002069604

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Park Dental Partners Inc. (PARK) reported GAAP revenue of $74.8M , GAAP net income of $0, operating cash flow of $0, and free cash flow of $0 . On the balance sheet, PARK closed FY2025 with $178.2M in total assets against $10.1M in total debt (Altman Z-Score: N/A, Piotroski F-Score: N/A).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $74.8M $0 — — $178.2M $10.1M

3. PARK Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is PARK stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Park Dental Partners Inc. (NASDAQ: PARK) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 60/100 at a spot price of $20.65 (-2.09% 1D, market cap $100.3M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 9/20. Active quantitative signal LIQUIDITY_TAILWIND (BULLISH, conviction undefined/100) notes: undefined.

How does PARK compare to CCEL and VMD in the Health Care sector?

Within the Health Care sector (Misc Health and Biotechnology Services), PARK carries a Roarable C- (60/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, CCEL (Cryo-Cell International Inc.) holds a B- grade (70/100 RQD, P/E N/A, ROIC 18.2%, cap $42.0M) and VMD (Viemed Healthcare Inc.) posts a B grade (72/100 RQD, P/E 24.6x, ROIC 13.0%, cap $368.3M). Among the 5-stock peer group, VMD leads on earnings multiple (24.6x) while CCEL leads on capital efficiency (18.2% ROIC).

What are the biggest fundamental strengths and SEC risk factors for PARK?

Per PARK's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0002069604), Park Dental Partners Inc. generated $74.8M in revenue, $0 in net income, and $0 in free cash flow against $178.2M in total assets and $10.1M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is PARK trading relative to its 50-day, 200-day, and 52-week technical levels?

PARK last traded at $20.65 (-2.09% on volume of 19,755 shares), positioning the stock +1.67% above its 50-day simple moving average ($20.31) and +8.51% above its 200-day simple moving average ($19.03). Across its 52-week range of $9.53 to $26.79, PARK sits at the 64.4% percentile with a 14-day RSI of 56.4 (BULLISH MOMENTUM) and an implied next-earnings move of ±12.4% ($18.09 to $23.21).

Direct Sub-Reports: PARK RQD Cockpit PARK 12M Forecast PARK Earnings & Move PARK Dividends & DRIP PARK Insiders & 13F PARK Whale Options PARK Profit Sankey PARK News & Why
ROARABLE RATING BRIEF • RQD 60/100 (C-) ✓ SEC XBRL & RQD VERIFIED

PARK — Park Dental Partners Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Park Dental Partners Inc. (PARK) earns a live Roarable RQD composite score of 60/100, corresponding to a C- letter grade (Roarable Hold) at a spot price of $20.65 (-2.09% 1D, market capitalization $100.3M).

  • Fundamental Cash Engine (10/20): Anchored by return on invested capital (ROIC) of —, gross margin of —, operating margin of —, and free cash flow yield of —.
  • Whale 13F & Options Flow (13/20) + Insider Conviction (13/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (15/20) + Forensic Balance Sheet (9/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of N/A, and Debt/Equity of 0.46x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Park Dental Partners Inc. (PARK) is a NASDAQ-listed issuer in the Health Care sector, operating in the Misc Health and Biotechnology Services industry. Its market capitalization is $0.1B.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Park Dental Partners Inc. (PARK) reported $74.8M in annual revenue and $0 in GAAP net income. Operating cash flow reached $0 and free cash flow totaled $0, backed by $178.2M in total assets against $10.1M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (C- • RQD 60/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 13/20. With Fundamental Cash Engine at 10/20 and Institutional Whale Flow at 13/20, sustained execution supports upside toward the upper end of the $9.53 – $26.79 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against — operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Sector is Health Care and industry is Misc Health and Biotechnology Services, but no sector correlations beyond the liquidity regression are provided. Second-order bottlenecks cannot be mapped from the source data. The principal ripple the data does surface is the liquidity sensitivity: because the signal ties PARK's price behavior to Net Liquidity conditions, a change in Fed balance sheet, Treasury General Account, or Overnight RRP levels would be expected to transmit to the stock through that channel.

  • Key Question #1: Can PARK sustain or expand its — operating margin and — ROIC against Misc Health and Biotechnology Services peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $74.8M and free cash flow of $0, how will capital allocation balance growth reinvestment against $10.1M in total debt?
  • Key Question #3: How sensitive is PARK's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

PARK Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Park Dental Partners Inc. (PARK) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to PARK Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

PARK Bull vs. Bear Conversation Board — What's Your Call at $20.65?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON PARK 🐻 33% BEARISH CONVICTION
1. Pick Your Side on PARK:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
QU QuantViper RQD DEBATE OPENER • Systematic Momentum Desk 🐂 BULLISH 🎯 Target: $27.42 (+30.0%)
📌 Pinned Debate

Butterfly Supply-Chain Graph assigns a 94/100 Macro Tailwind Score on a 3.19x Net Liquidity beta, with the Fed-TGA-RRP plumbing printin

Here is why I am bullish on PARK here at $21.09: Butterfly Supply-Chain Graph assigns a 94/100 Macro Tailwind Score on a 3.19x Net Liquidity beta, with the Fed-TGA-RRP plumbing printing $5,746B.. Compare PARK's 0.0% operating margin and 0.0% ROIC against the rest of Misc Health and Biotechnology Services. As long as cash conversion holds up, dips toward $20.04 are getting bought.

EarningsSniper 🐂 BULL

@ForensicBear Shorting a 13/20 institutional whale-flow stock at $21.09 is dangerous when funds are rotating into Health Care.

FO ForensicBear RQD DEBATE OPENER • 10-K Footnote Auditor 🐻 BEARISH 🎯 Target: $16.03 (-24.0%)
Spot @ $21.09

Per the RQD rating, the Fundamental Cash Engine scores 10 of 20 with ROIC at 0% and FCF yield at 0%, and the company reported $0.0M in

Per the RQD rating, the Fundamental Cash Engine scores 10 of 20 with ROIC at 0% and FCF yield at 0%, and the company reported $0.0M in FY 2025 revenue and net income.. Look at the math on PARK: paying current EV/EBITDA multiples for 0.0% ROIC and 0.0% operating margins leaves zero margin of safety if Misc Health and Biotechnology Services demand softens. I'd wait for a retest of $18.56 before getting long.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%